10:34am Thursday 21 September 2017

Chromosomal abnormalities may explain increased cancer risk in type 2 diabetes

This finding may provide a partial explanation for the higher rates of cancer-related mortality observed among patients with this type of diabetes. These results were obtained by a French-British-Qatari research group coordinated by Professor Philippe Froguel in the Laboratoire Génomique et maladies métaboliques (CNRS/Université Lille 2/Institut Pasteur de Lille), working in collaboration with teams attached to INSERM, AP-HP (Paris Public Hospitals) Paris Diderot and Paris-Sud universities . Their work was published on July 14, 2013 on the Nature Genetics website.


To download the press release : CP_DT2


Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Amélie Bonnefond, Boris Skrobek, Stéphane Lobbens, Elodie Eury, Dorothée Thuillier, Stéphane Cauchi, Olivier Lantieri, Beverley Balkau, Elio Riboli, Michel Marre, Guillaume Charpentier, Loïc Yengo & Philippe Froguel. Nature Genetics. 14 July 2013. DOI : 10.1038/ng.2700

Contact information:

Researcher l Philippe Froguel l T +33 (0)3 20 87 79 54 / 79 11 l p.froguel@imperial.ac.uk

CNRS Press officer l Priscilla Dacher l T +33 (0)1 44 96 46 06 l priscilla.dacher@cnrs-dir.fr

Share on:

Health news